Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its...
Clinical Trials
Clinerion received ISO 27001:2013 certification
Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS).
ISO 27001:2013 is a standard...
News
COVID-19 and the pharma supply chain – How to manage your pharmaceutical logistics in difficult times
With panic buying of face masks and no hand sanitiser on chemists’ shelves, there is no doubt that the latest COVID-19 outbreak is having...
Articles
The unexpected benefits of clinical trial disclosure
Introduction:
Patients, clinical trial sponsors and institutions are starting to benefit from increased transparency commitments and significant investments in trial data disclosure. To make an...
Drug Research
Sinclair Research Announces Toxicology Laboratory Expansion
Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot laboratory expansion later this spring. The additional capacity will...
News
FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19
Thermo Fisher Scientific Inc., the world leader in serving science, announced that the U.S. Food and Drug Administration (FDA) has issued an emergency use...
Press Releases
EC approves Alnylams Givlaari for acute hepatic porphyria
The European Commission (EC) has approved Alnylam’s Givlaari (givosiran) for adults and adolescents with acute hepatic porphyria (AHP).
Givlaari was previously granted priority medicines designation...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read